Intellia Therapeutics
Earnings Surprise
Analysts estimated NTLA earnings of $-0.97 per share this quarter (Q4). NTLA's actual earnings were $-0.83 per share.
NTLA EPS surprise of 14.78%Analysts estimated NTLA earnings of $-1.02 per share this quarter (Q3). NTLA's actual earnings were $-0.92 per share.
NTLA EPS surprise of 9.97%Analysts estimated NTLA earnings of $-1.04 per share this quarter (Q2). NTLA's actual earnings were $-0.98 per share.
NTLA EPS surprise of 5.61%Analysts estimated NTLA earnings of $-1.31 per share this quarter (Q1). NTLA's actual earnings were $-1.10 per share.
NTLA EPS surprise of 15.91%Analysts estimated NTLA earnings of $-1.36 per share this quarter (Q4). NTLA's actual earnings were $-1.27 per share.
NTLA EPS surprise of 6.34%Analysts estimated NTLA earnings of $-1.41 per share this quarter (Q3). NTLA's actual earnings were $-1.34 per share.
NTLA EPS surprise of 5.12%Analysts estimated NTLA earnings of $-1.26 per share this quarter (Q2). NTLA's actual earnings were $-1.52 per share.
NTLA EPS surprise of -20.94%Analysts estimated NTLA earnings of $-1.41 per share this quarter (Q1). NTLA's actual earnings were $-1.12 per share.
NTLA EPS surprise of 20.40%Analysts estimated NTLA earnings of $-1.48 per share this quarter (Q4). NTLA's actual earnings were $-1.46 per share.
NTLA EPS surprise of -1.22%